12:00 AM
 | 
Sep 20, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Benlysta belimumab regulatory update

FDA's Arthritis Advisory Committee will meet on Nov. 16 to discuss a BLA from Human Genome Sciences for Benlysta belimumab to treat...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >